Walter V. Klemp, CEO and President at Moleculin Biotech, Inc. (MBRX), bought 1,364,090 shares at $0.37 ($500K) on 2025-06-23, disclosed to the SEC on 2025-06-23.
Seasonal purchase ($500k) by CEO and President — this insider has traded MBRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,750 | $0 | 0.0% |
| 2 | $0.00 | 8,990 | $0 | 0.0% |
| 3 | $0.37 | 675,675 | $250K | 50.0% |
| 4 | $0.37 | 675,675 | $250K | 50.0% |
| Total | $0.37 avg | 1,364,090 | $500K | 100% |
| Filing → |
| MBRX | BUY | 2022-11-23 | $26K | — | Filing → |
| MBRX | BUY | 2022-11-18 | $191K | — | Filing → |
| MBRX | SELL | 2017-08-18 | $170K | — | Filing → |